MULTI BARRIER REVERSE CONVERTIBLE - GIVAUDAN/ABB LTD/NOVARTIS N/ROCHE GS Share Price

Certificat

MHCRCH

CH1259329311

Market Closed - Swiss Exchange 16:20:01 07/05/2024 BST
99.71 CHF +0.16% Intraday chart for MULTI BARRIER REVERSE CONVERTIBLE - GIVAUDAN/ABB LTD/NOVARTIS N/ROCHE GS
Current month+0.34%
1 month+0.81%
Date Price Change Volume
07/05/24 99.71 +0.16% 0
06/05/24 99.55 +0.07% 0
03/05/24 99.48 +0.11% 0

Delayed Quote Swiss Exchange

Last update May 07, 2024 at 04:20 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Raiffeisen Switzerland B.V.
MHCRCH
ISINCH1259329311
Date issued 05/05/2023
Strike 283.7 CHF
Maturity 05/11/2025 (545 Days)
Parity 0.28 : 1
Emission price 100 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 102.4 CHF
Lowest since issue 96.68 CHF
Spread 8 CHF
Spread %0.80%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
222.3 CHF
Average target price
279.4 CHF
Spread / Average Target
+25.68%
Consensus
  1. Stock Market
  2. Certificates
  3. MHCRCH Certificat